Dec 14 Biotime Inc
* Biotime Inc says it has achieved an important patient enrollment milestone in its renevia pivotal trial in europe
* Biotime Inc - remains on track for top-line data by middle of 2017 for renevia pivotal study
* Biotime achieves patient recruitment milestone in renevia pivotal trial
* Biotime Inc says now has more than 50 patients in trial, keeping it on track with anticipated forecast for top-line data by middle of 2017
* Biotime Inc says remains on track for top-line data by middle of 2017
* Biotime Inc - also actively working on plans for other large aesthetic markets like South Korea and Brazil as well as U.S for renevia Source text for Eikon: Further company coverage:
Chinese court rules in favour of Apple in local design patent disputes
BEIJING, March 25 A Chinese court has ruled in favour of Apple in design patent disputes between the Cupertino, California company and a domestic phone-maker, overturning a ban on selling iPhone 6 and iPhone 6 Plus phones in China, Xinhua news agency reported.
China's C919 passenger jet moves closer to maiden flight - Xinhua
BEIJING, March 25 China's C919 passenger jet, the symbol of its lofty aviation ambitions, has passed a major technical assessment, and has moved closer to its first flight, the official Xinhua news agency reported on Saturday.